26779. Adulteration and misbranding of atropine sulphate tablets, tincture of aconite tablets, atropine sulphate solution, and sodium cacodylate ampoules. J. S. v. The Columbus Pharmacal Co. Plea of guilty. Fine, $1,200. (F. & D. no. 36035. Sample Mes. 35175-B, 35234-B, 35241-B, 35248-B.) This case involved drugs that fell below the professed standard and quality under which they were sold. On April 16, 1936, the United States attorney for the Southern District of Ohio, acting upon a report by the Secretary of Agriculture, filed in the district court an information against the Columbus Pharmacal Co., a corporation, Columbus, Ohio, alleging shipment by said company, in violation of the Food and Drugs Act on or about April 30 and May 22, 1935, from the State of Ohio into the State of Indiana of quantities of drugs that were adulterated and misbranded. The articles were labeled in part variously: "Tablets Atro- pine Sulphate 1-150 grain * * * The Columbus Pharmacal Company"; "Tablets Aconite Tincture * * * 2 minims"; "Ophthalmic Solution * * * Atropine Sulphate 2%"; "1 cc. Size Sodium Cacodylate 0.2 Gm. (3 grs.)." The articles were alleged to be adulterated in that their strength and purity fell below the professed standard and quality under which they were sold in the following respects: Each of the atropine sulphate tablets was repre- sented to contain 1-150 grain of atropine sulphate; whereas eaeh of said tablets contained less, namely, not more than 1/200 grain, of atropine sulphate; each of the tincture of aconite tablets was represented to contain 2 minims of tinc- ture of aconite, whereas each of said tablets contained less, namely, not more than 0.25 minim, of tincture of aconite; the solution of atropine sulphate was represented to contain 2 percent of atropine sulphate; whereas it contained less, namely, not more than 1.83 percent of atropine sulphate; each cubic centimeter of the sodium cacodylate was represented to contain 0.2 gram (3 grains) of sodium cacodylate; whereas each cubic centimeter of the article contained less than represented, namely, not more than 0.16 gram (2% grains) of sodium cacodylate. The articles were alleged to be misbranded in that the statements, "Tablets Atropine Sulphate 1-150 grain", "Tablets Aconite Tincture * * * 2 minims", "Solution * * * Atropine Sulphate 2%", and "1 cc. * * * So- dium Cacodylate 0.2 Gm. (3 grs.)", borne on the labels, were false and mis- leading. On January 28, 1937, the defendant entered a plea of guilty and on Febru- ary 4,1937, the court imposed a fine of $1,200. W. R. GBEGG, Acting Secretary of Agriculture.